The effect of point mutations within the N-terminal domain of Mason-Pfizer monkey virus capsid protein on virus core assembly and infectivity

Virology

Volumn 380, Issue 1, 2008, Pages 157-163

  Wildová, Marcela ^a   Hadravová, Romana ^a   Štokrová, Jitka ^a   Křížová, Ivana ^a   Ruml, Tomáš ^a,b   Hunter, Eric ^c   Pichová, Iva ^a   Rumlová, Michaela ^a,b  

^a INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^b INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

^c EMORY UNIVERSITY   (United States)

Author keywords

hairpin; Assembly; Capsid protein; M PMV; Retrovirus

Indexed keywords

ASPARTIC ACID; CAPSID PROTEIN; GAG PROTEIN; PROLINE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MASON PFIZER MONKEY VIRUS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PROCESSING; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS INFECTIVITY; VIRUS PARTICLE;

CAPSID PROTEINS; MASON-PFIZER MONKEY VIRUS; POINT MUTATION; VIRION; VIRUS ASSEMBLY;

MASON-PFIZER MONKEY VIRUS; MIRIDAE; PAPAYA MOSAIC VIRUS;

EID: 52049096820     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.07.021     Document Type: Article

References (31)

1. Abdurahman S., Youssefi M., Hoglund S., and Vahlne A. Characterization of the invariable residue 51 mutations of human immunodeficiency virus type 1 capsid protein on in vitro CA assembly and infectivity. Retrovirology 4 (2007) 69
2. Auerbach M.R., Brown K.R., and Singh I.R. Mutational analysis of the N-Terminal domain of Moloney murine leukemia virus capsid protein. J. Virol. 81 (2007) 12337-12347
3. Bouamr F., Cornilescu C.C., Goff S.P., Tjandra N., and Carter C.A. Structural and dynamics studies of the D54A mutant of human T cell leukemia virus-1 capsid protein. J. Biol. Chem. 280 (2005) 6792-6801
4. Brody B.A., and Hunter E. Mutations within the env gene of Mason-Pfizer monkey virus: effects on protein transport and SU-TM association. J.Virol. 66 (1992) 3466-3475
5. Campos-Olivas R., Newman J.L., and Summers M.F. Solution structure and dynamics of the Rous sarcoma virus capsid protein and comparison with capsid proteins of other retroviruses. J. Mol. Biol. 296 (2000) 633-649
6. Cornilescu C.C., Bouamr F., Yao X., Carter C., and Tjandra N. Structural analysis of the N-terminal domain of the human T-cell leukemia virus capsid protein. J. Mol. Biol. 306 (2001) 783-797
7. Forshey B.M., von Schwedler U., Sundquist W.I., and Aiken C. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J. Virol. 76 (2002) 5667-5677
8. Gamble T.R., Yoo S.H., Vajdos F.F., vonSchwedler U.K., Worthylake D.K., Wang H., McCutcheon J.P., Sundquist W.I., and Hill C.P. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 278 (1997) 849-853
9. Gamble T.R., Vajdos F.F., Yoo S., Worthylake D.K., Houseweart M., Sundquist W.I., and Hill C.P. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87 (1996) 1285-1294
10. Ganser-Pornillos B.K., von Schwedler U.K., Stray K.M., Aiken C., and Sundquist W.I. Assembly properties of the human immunodeficiency virus type 1 CA protein. J. Virol. 78 (2004) 2545-2552
11. Ganser-Pornillos B.K., Cheng A., and Yeager M. Structure of full-length HIV-1 CA: a model for the mature capsid lattice. Cell 131 (2007) 70-79
12. Gitti R.K., Lee B.M., Walker J., Summers M.F., Yoo S., and Sundquist W.I. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science 273 (1996) 231-235
13. Gross I., Hohenberg H., Huckhagel C., and Krausslich H.G. N-terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles. J. Virol. 72 (1998) 4798-4810
14. Jin Z., Jin L., Peterson D.L., and Lawson C.L. Model for lentivirus capsid core assembly based on crystal dimers of EIAV p26. J. Mol. Biol. 286 (1999) 83-93
15. Khorasanizadeh S., Campos-Olivas R., and Summers M.F. Solution structure of the capsid protein from the human T-cell leukemia virus type-I. J. Mol. Biol. 291 (1999) 491-505
16. Kingston R.L., Fitzon-Ostendorp T., Eisenmesser E.Z., Schatz G.W., Vogt V.M., Post C.B., and Rossmann M.G. Structure and self-association of the Rous sarcoma virus capsid protein. Struc. Fold. Des. 8 (2000) 617-628
17. Leschonsky B., Ludwig C., Bieler K., and Wagner R. Capsid stability and replication of human immunodeficiency virus type 1 are influenced critically by charge and size of Gag residue 183. J. Gen. Virol. 88 (2007) 207-216
18. Momany C., Kovari L.C., Prongay A.J., Keller W., Gitti R.K., Lee B.M., Gorbalenya A.E., Tong L., McClure J., Ehrlich L.S., Summers M.F., Carter C., and Rossmann M.G. Crystal structure of dimeric HIV-1 capsid protein. Nat. Struct. Biol 3 (1996) 763-770
19. Mortuza G.B., Haire L.F., Stevens A., Smerdon S.J., Stoye J.P., and Taylor I.A. High-resolution structure of a retroviral capsid hexameric amino-terminal domain. Nature 431 (2004) 481-485
20. Mortuza G.B., Dodding M.P., Goldstone D.C., Haire L.F., Stoye J.P., and Taylor I.A. Structure of B-MLV capsid amino-terminal domain reveals key features of viral tropism, Gag assembly and core formation. J. Gen. Virol. 376 (2008) 1493-1508
21. Nandhagopal N., Simpson A.A., Johnson M.C., Francisco A.B., Schatz G.W., Rossmann M.G., and Vogt V.M. Dimeric Rous sarcoma virus capsid protein structure relevant to immature Gag assembly. J. Mol. Biol. 335 (2004) 275-282
22. Newman R.M., Hall L., Connole M., Chen G.L., Sato S., Yuste E., Diehl W., Hunter E., Kaur A., Miller G.M., and Johnson W.E. Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5{alpha}. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 19134-19139
23. Parker S.D., and Hunter E. Activation of the Mason-Pfizer monkey virus protease within immature capsids in vitro. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 14631-14636
24. Pettit S.C., Henderson G.J., Schiffer C.A., and Swanstrom R. Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease. J. Virol. 76 (2002) 10226-10233
25. Rayne F., Bouamr F., Lalanne J., and Mamoun R.Z. The NH2-terminal domain of the human T-cell leukemia virus type 1 capsid protein is involved in particle formation. J. Virol. 75 (2001) 5277-5287
26. Rumlova M., Ruml T., Pohl J., and Pichova I. Specific in vitro cleavage of Mason-Pfizer monkey virus capsid protein: evidence for a potential role of retroviral protease in early stages of infection. Virology 310 (2003) 310-318
27. Rumlova-Klikova M., Hunter E., Nermut M.V., Pichova I., and Ruml T. Analysis of Mason-Pfizer monkey virus gag domains required for capsid assembly in bacteria: role of the N-terminal proline residue of CA in directing particle shape. J. Virol. 74 (2000) 8452-8459
28. Stansell E., Apkarian R., Haubova S., Diehl W.E., Tytler E.M., and Hunter E. Basic residues in the Mason-Pfizer monkey virus Gag matrix domain regulate intracellular trafficking and capsid-membrane interactions. J. Virol. 81 (2007) 8977-8988
29. Strambio-de-Castillia C., and Hunter E. Mutational analysis of the major homology region of Mason-Pfizer monkey virus by use of saturation mutagenesis. J. Virol. 66 (1992) 7021-7032
30. von Schwedler U.K., Stemmler T.L., Klishko V.Y., Li S., Albertine K.H., Davis D.R., and Sundquist W.I. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. Embo. J. 17 (1998) 1555-1568
31. von Schwedler U.K., Stray K.M., Garrus J.E., and Sundquist W.I. Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J. Virol. 77 (2003) 5439-5450